MARKET WATCH: Could GSK jab lower risk of Dementia? Drugs giant to trial its shingles jab as a cure for the disease

Daily Mail // Business // Money

MARKET WATCH: Could GSK jab lower risk of Dementia? Drugs giant to trial its shingles jab as a cure for the disease

Tuesday 25th March 2025, 10:00PM

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its Shingrix shot.

Full Story